Type XIII collagen expression is induced during malignant transformation in various epithelial and mesenchymal tumours

Journal of Pathology

Volumn 207, Issue 3, 2005, Pages 324-335

  Väisänen, Timo ^a   Väidänen, Marja Riitta ^a   Autio Harmainen, Helena ^a   Pihlajaniemi, Taina ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Collagen type XIII; Extracellular matrix; Malignant transformation; Tissue microarray

Indexed keywords

COLLAGEN TYPE 13; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN;

ARTICLE; CANCER CELL; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; EPITHELIUM TUMOR; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; MESENCHYME; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TISSUE MICROARRAY;

CELL ADHESION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLLAGEN TYPE XIII; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESODERM; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PHENOTYPE; PLACENTA; PREGNANCY; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; STROMAL CELLS; UP-REGULATION; VITRONECTIN;

EID: 27644508833     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1836     Document Type: Article

References (66)

1. Sung SY, Chung LWK. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation 2002;70:506-521.
2. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 2002;62:3298-3307.
3. Hagedorn H, Sauer U, Schleicher E, Nerlich A. Expression of TGF-β1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas. Anticancer Res 1999;19:4265-4272.
4. Seljelid R, Jozefowski S, Sveinbjornsson B. Tumor stroma. Anticancer Res 1999;19:4809-4822.
5. Berking C, Takemoto R, Schaider H, Showe L, Satyamoorty K, Robbins P, et al. Transforming growth factor-β1 increases survival of human melanoma through stroma remodeling. Cancer Res 2001; 61:8306-8316.
6. Fujimoto K, Sheng H, Shao J, Beauchamp RD. Transforming growth factor-β1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells. Exp Cell Res 2001;266:239-249.
7. Löhr M, Schmidt C, Ringel J, Kluth M, Muller P, Nizze H, et al. Transforming growth factor-β1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res 2001;61:550-555.
8. Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, et al. Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin. Am J Pathol 2002;161:183-193.
9. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002;8:2912-2923.
10. Faouzi S, Le Bail B, Neaud V, Boussarie L, Saric J, Bioulac-Sage P, et al. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 1999;30:275-284.
11. Bridle KR, Crawford DH, Powell LW, Ramm GA. Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis. Liver 2001;21:96-104.
12. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
13. Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001;11:S37-S43.
14. Weaver VM, Gilbert P. Watch thy neighbor: cancer is a communal affair. J Cell Sci 2004;117:1287-1290.
15. Kataoka H, Tanaka H, Nagaike K, Uchiyama S, Itoh H. Role of cancer cell-stroma interaction in invasive growth of cancer cells. Hum Cell 2003;16:1-14.
16. Quaranta V, Giannelli G. Cancer invasion: watch your neighbourhood! Tumori 2003;89:343-348.
17. Arnold JT, Kaufman DG, Seppälä M, Lessey BA. Endometrial stromal cells regulate epithelial cell growth in vitro:a new co-culture model. Hum Rep 2001;16:836-845.
18. Vu TH. Don't mess with the matrix. Nature Genet 2001;28:202-203.
19. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem 1998;273:9711-9717.
20. Hägg P, Rehn M, Huhtala P, Väisänen T, Tamminen M, Pihlajaniemi T. Type XIII collagen is identified as a plasma membrane protein. J Biol Chem 1998;273:15 590-15 597.
21. Schäcke H, Schumann H, Hammami-Hauasli N, Raghunath M, Bruckner-Tuderman L. Two forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomain. J Biol Chem 1998;73:25 937-25 943.
22. Hashimoto T, Wakabayashi T, Watanabe A, Kowa H, Hosoda R, Nakamura A, et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J 2002;21:1524-1534.
23. Banyard J, Bao L, Zetter BR. Type XXIII collagen, a new transmembrane collagen identified in metastasic tumor cells. J Biol Chem 2003;278:20989-20994.
24. Pihlajaniemi T, Myllylä R, Seyer J, Kurkinen M, Prockop DJ. Partial characterization of a low molecular weight human collagen that undergoes alternative splicing. Proc Natl Acad Sci U S A 1987;84:940-944.
25. Sandberg M, Tamminen M, Hirvonen H, Vuorio E, Pihlajaniemi T. Expression of mRNAs coding for the α1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II and III. J Cell Biol 109:1371-1379.
26. Pihlajaniemi T, Tamminen M. The α1 chain of type XIII collagen consists of three collagenous and four noncollagenous domains, and its primary transcript undergoes complex alternative splicing. J Biol Chem 1990;265:16922-16928.
27. Juvonen M, Pihlajaniemi T, Autio-Harmainen H. Location and alternative splicing of type XIII collagen mRNA in the early human placenta. Lab Invest 1993;69:541-551.
28. Sund M, Väisänen T, Kaukinen S, Ilves M, Tu H, Autio-Harmainen H, et al. Distinct expression of type XIII collagen in neuronal structures and other tissues during mouse development. Matrix Biol 2001;20:215-231.
29. Hägg P, Väisänen T, Tuomisto A, Rehn M, Tu H, Huhtala P, et al. Type XIII collagen: a novel cell adhesion component present in a range of cell-matrix adhesions and in the intercalated discs between cardiac muscle cells. Matrix Biol 2001;19:727-742.
30. Snellman A, Tu H, Väisänen T, Kvist A-P, Huhtala P, Pihlajaniemi T. A short sequence in the N-terminal region is required for the trimerization of type XIII collagen and is conserved in other collagenous transmembrane proteins. EMBO J 2000;19:5051-5059.
31. Väisänen M-R, Väisänen T, Pihlajaniemi T. The shed ectodomain of type XIII collagen affects cell behaviour in a matrix-dependent manner. Biochem J 2004;380:1-9.
32. Tu H, Sasaki T, Snellman A, Gohring W, Pirilä P, Timpl R, et al. The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin. J Biol Chem 2002;277:23 092-23 099.
33. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 1998;4:844-847.
34. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, et al. Survey of gene amplification during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999;59:803-806.
35. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-1949.
36. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DHY, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-1251.
37. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Med 2002;8:1323-1327.
38. Harlow E, Lane D. In Antibodies: a Laboratory Manual (1st edn), Harlow E, Lane D (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, New York, 1988; 72-120 511-552.
39. Bachmeier BE, Nerlich AG, Boukamp P, Lichtinghagen R, Tschesche H, Fritz H, et al. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1, -8, and -13 and of TIMP-1. Biol Chem 2000;381:509-516.
40. Arnold JT, Lessey BA, Seppälä M, Kaufman DG. Effect of normal endometrial stroma on growth and differentiation in Ischikawa endometrial adenocarcinoma cells. Cancer Res 2002;62:79-88.
41. Kissin EY, Lemaire R, Korn JH, Lafyatis R. Transforming growth factor β induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum 2002;46:3000-3009.
42. Kubota K, Okazaki J, Louie O, Kent KC, Liu B. TGF-β stimulates collagen (I) in vascular smooth muscle cells via short element in the proximal collagen promoter. J Surg Res 2003;109:43-50.
43. Mizokami T, Salvi M, Wall JR. Eye muscle antibodies in Grave's ophthalmopathy: pathogenic or secondary epiphenomenon? J Endocrin Invest 2004;27:221-229.
44. Parikka M, Kainulainen T, Tasanen K, Väänänen A, Bruckner-Tuderman L, Salo T. Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma. J Histochem Cytochem 2003;51:921-929.
45. Brown LF, Guidi AJ, Schnitt SJ, van de Water L, Iruela-Arispe ML, Yeo TK, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-1056.
46. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. Paracrine cells important in health and disease. Am J Physiol 1999;277:C1-C19.
47. Bode MK, Karttunen TJ, Mäkelä J, Risteli L, Risteli J. Type I and III collagens in human colon cancer and diverticulosis. Scand J Gastroenterol 2000;35:747-752.
48. Burns-Cox N, Avery NC, Gingell JC, Bailey AJ. Changes in collagen metabolism in prostate cancer: a host response that may alter progression. J Urol 2001;166:1698-1701.
49. Fisher H, Sternling R, Rubio C, Lindblom A. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001;22:875-878.
50. Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP, et al. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 2001;34:82-88.
51. Ronnov-Jessen L, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993;68:696-707.
52. Valenti MT, Azzarello G, Balducci E, Sartore S, Sandri S, Manconi R, et al. Conditioned medium from MCF-7 cell line induces myofibroblast differentiation, decreased cell proliferation, and increased apoptosis in cultured normal fibroblasts but not in fibroblasts from malignant breast tissue. Histochem J 2001;33:499-509.
53. Petrov VV, Fagard RH, Lijnen PJ. Stimulation of collagen production by transforming growth factor-β1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002;39:258-263.
54. Serini G, Gabbiani G. Minireview: Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999;250:273-283.
55. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nature Rev Mol Cell Biol 2002;3:349-363.
56. Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 2001;25:39-50.
57. Ignotz RA, Endo T, Massagúe J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem 1987;262:6443-6446.
58. Kähäri V-M, Peltonen J, Chen YQ, Uitto J. Differential modulation of basement membrane gene expression in human fibrosarcoma HT-1080 cells by transforming growth factor-β1. Lab Invest 1991;64:807-818.
59. Frazer A, Bunning RA, Thavarajah M, Seid JM, Russell RG. Studies on type II collagen and aggrecan production in human articular chondrosytes in vitro and effects of transforming growth factor-β and interleukin-1β. Osteoarthritis Cartilage 1994;2:235-245.
60. Taipale J, Koli K, Keski-Oja J. Release of transforming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 1992;267:25 378-25 384.
61. Liu C, Adamson E, Mercola D. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor-β1. Proc Natl Acad Sci U S A 1996;93:11831-11836.
62. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, et al. A transforming growth factor-β1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003;63:2610-2615.
63. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001;276:17 058-17 062.
64. Aaboe M, Offersen BV, Christensen A, Andreasen PA. Vitronectin in human breast carcinomas. Biochim Biophys Acta 2003;1638:72-82.
65. Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 2001;276:18 415-18 422.
66. Bosserhoff AK, Stoll R, Sleeman JP, Bataille F, Buettner R, Holak T. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab Invest 2003;83:1583-1594.